Hua-Liang Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hua-Liang Xiao has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Dao-Cheng Liu
State Key Laboratory of Trauma, Burns and Combined Injury, Trauma Center, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, 400042, China
1 shared publication - Hao Tan
State Key Laboratory of Trauma, Burns and Combined Injury, Trauma Center, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, 400042, China
1 shared publication - Hui-Jun Niu
Department of Thoracic Surgery, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Changjiang Route 10#, Chongqing, PR China
1 shared publication Jin-Hua Chen
Third Military Medical University
1 shared publication- Lianyang Zhang
Department of Emergency Medicine, Medical Center of Trauma and War Injury, Daping Hospital, State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University, Chongqing, China
1 shared publication Qun-You Tan
Third Military Medical University
1 shared publication
Latest Publications
- Open Access
- 15 April 2014
- Published by Elsevier in Military Medical Research
- Vol. 1 (1) , 4
Effect of intra-abdominal volume increment on kidneys in minipigs with intra-abdominal hypertension after hemorrhagic shock and resuscitation
- 15 April 2014
- Published by Elsevier in Military Medical Research
- Vol. 1 (1) , 4
Open AccessEffect of intra-abdominal volume increment on kidneys in minipigs with intra-abdominal hypertension after hemorrhagic shock and resuscitation
- 9 November 2012
- Published by Springer Nature in Surgery Today
- Vol. 43 (6) , 690-693
Pulmonary adenofibroma in a middle-aged man: report of a case
We report a case of pulmonary adenofibroma, a rare benign soft-tissue tumor characterized by a combination of glandular and spindle stromal elements, in a 55-year-old man. This case is interesting because of the unusual X-ray and computed tomography (CT) imaging findings of a well-defined, subpleural soft-tissue nodule in the inferior lobe of the left lung, which showed no enhancement after contrast scan. The tumor was resected completely via video-assisted thoracoscopy. Microscopic and immunohistochemical examinations supported the diagnosis of a benign pulmonary adenofibroma. The patient remains well with no evidence of recurrence 16 months after surgery. Although the imaging findings were nonspecific, adenofibroma may be one of diagnostic inclusions of soft-tissue nodules of the lung in middle-aged patients.
- 9 November 2012
- Published by Springer Nature in Surgery Today
- Vol. 43 (6) , 690-693
Pulmonary adenofibroma in a middle-aged man: report of a case
We report a case of pulmonary adenofibroma, a rare benign soft-tissue tumor characterized by a combination of glandular and spindle stromal elements, in a 55-year-old man. This case is interesting because of the unusual X-ray and computed tomography (CT) imaging findings of a well-defined, subpleural soft-tissue nodule in the inferior lobe of the left lung, which showed no enhancement after contrast scan. The tumor was resected completely via video-assisted thoracoscopy. Microscopic and immunohistochemical examinations supported the diagnosis of a benign pulmonary adenofibroma. The patient remains well with no evidence of recurrence 16 months after surgery. Although the imaging findings were nonspecific, adenofibroma may be one of diagnostic inclusions of soft-tissue nodules of the lung in middle-aged patients.
- Open Access
- 20 October 2011
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 9 (1) , 134
Retrospective analysis for thirty-nine patients with solitary fibrous tumor of pleura and review of the literature
Background: Solitary fibrous tumor of the pleura (SFTP) is an uncommon neoplasm arising from mesenchymal cells. The aim of this study is to summarize the experience and the outcome of the surgical treatment for 39 cases of SFTP. Methods: From January 2004 to December 2008, 39 patients underwent surgical resection of SFTP in our department. All patients had clinical follow-up by the same team of surgeons. The mean follow-up was 40.3 months. Results: A local removal of the neoplasm was accomplished by video-assisted thoracic surgery (VATS) in 9 patients (group A) and by thoracotomy in 30 patients (group B) respectively. Comparing with group B, operations in group A took significantly less operative time, blood loss and spent less time in the intensive care unit and hospital. All specimens were positive for CD34 and Bcl-2. One patient developed recurrence, and the remaining 38 patients are alive and disease free at the end of follow-up. Conclusions: Malignant SFTP still had the potential recurrence. VATS represents the more acceptable choice for the selected patients with SFTP.
- 20 October 2011
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 9 (1) , 134
Open AccessRetrospective analysis for thirty-nine patients with solitary fibrous tumor of pleura and review of the literature
Background: Solitary fibrous tumor of the pleura (SFTP) is an uncommon neoplasm arising from mesenchymal cells. The aim of this study is to summarize the experience and the outcome of the surgical treatment for 39 cases of SFTP. Methods: From January 2004 to December 2008, 39 patients underwent surgical resection of SFTP in our department. All patients had clinical follow-up by the same team of surgeons. The mean follow-up was 40.3 months. Results: A local removal of the neoplasm was accomplished by video-assisted thoracic surgery (VATS) in 9 patients (group A) and by thoracotomy in 30 patients (group B) respectively. Comparing with group B, operations in group A took significantly less operative time, blood loss and spent less time in the intensive care unit and hospital. All specimens were positive for CD34 and Bcl-2. One patient developed recurrence, and the remaining 38 patients are alive and disease free at the end of follow-up. Conclusions: Malignant SFTP still had the potential recurrence. VATS represents the more acceptable choice for the selected patients with SFTP.